382 related articles for article (PubMed ID: 23625211)
1. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
Beckman JA; Paneni F; Cosentino F; Creager MA
Eur Heart J; 2013 Aug; 34(31):2444-52. PubMed ID: 23625211
[TBL] [Abstract][Full Text] [Related]
2. Medical management of peripheral artery disease in diabetes mellitus.
Gutierrez A; Bhatt DL
Eur Heart J; 2015 Jun; 36(24):1494-5. PubMed ID: 26295080
[No Abstract] [Full Text] [Related]
3. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
4. Outcome studies in type 2 diabetes.
Hanefeld M
Curr Med Res Opin; 2005; 21 Suppl 1():S41-8. PubMed ID: 15811198
[TBL] [Abstract][Full Text] [Related]
5. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
[TBL] [Abstract][Full Text] [Related]
6. [Diabetes mellitus and coronary artery disease. Update on diagnosis and drug therapy].
Marx N; Blessing E
Dtsch Med Wochenschr; 2007 May; 132(19):1034-8. PubMed ID: 17476633
[No Abstract] [Full Text] [Related]
7. [What is the most effective approach to the reduction of cardiovascular risk in type-2 diabetes mellitus?].
Simon K; Dobó E; Nádasy T; Retih I; Rácz I
Orv Hetil; 2006 Aug; 147(31):1443-6. PubMed ID: 16981416
[TBL] [Abstract][Full Text] [Related]
8. What's new in type 2 diabetes?
McCarthy JC; Pearson RD
J Fam Pract; 2012 Nov; 61(11):646-51. PubMed ID: 23256094
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cardiovascular events in diabetes.
Sigal R; Malcolm J; Arnaout A
Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
[No Abstract] [Full Text] [Related]
10. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
Blinc A; Poredos P
Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
Chamberlain JJ; Johnson EL; Leal S; Rhinehart AS; Shubrook JH; Peterson L
Ann Intern Med; 2018 May; 168(9):640-650. PubMed ID: 29610837
[TBL] [Abstract][Full Text] [Related]
12. Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: another focus.
Tahrani AA
Int J Clin Pract; 2006 Nov; 60(11):1515; author reply 1515-6. PubMed ID: 17073848
[No Abstract] [Full Text] [Related]
13. [Differentiated treatment of diabetics with an acute coronary syndrome].
Hamm CW; Hamann A
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
[No Abstract] [Full Text] [Related]
14. Cardiovascular risk management in diabetes in primary care.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 Aug; 65(8):907-8. PubMed ID: 26228345
[TBL] [Abstract][Full Text] [Related]
15. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
Candido R; Zanetti M
Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
[TBL] [Abstract][Full Text] [Related]
16. New drugs and clinical trials in diabetes and hypertension.
Nilsson P
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():64-9. PubMed ID: 9288549
[TBL] [Abstract][Full Text] [Related]
17. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
Wienbergen H; Senges J; Gitt AK
Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
[No Abstract] [Full Text] [Related]
18. Cardiovascular rehabilitation increase arterial compliance in type 2 diabetic patients with coronary artery disease.
Mourot L; Boussuges A; Campo P; Maunier S; Debussche X; Blanc P
Diabetes Res Clin Pract; 2009 May; 84(2):138-44. PubMed ID: 19264372
[TBL] [Abstract][Full Text] [Related]
19. Interpreting clinical trials of diabetic dyslipidaemia: new insights.
Wierzbicki AS
Diabetes Obes Metab; 2009 Mar; 11(3):261-70. PubMed ID: 17645560
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
